PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1991 July; 84(7): 393–394.
PMCID: PMC1293325

Lipids in non-insulin dependent diabetes: a case for treatment?

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (459K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
 
 

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Panzram G. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1987 Mar;30(3):123–131. [PubMed]
  • Seviour PW, Teal TK, Richmond W, Elkeles RS. Serum lipids, lipoproteins and macrovascular disease in non-insulin-dependent diabetics: a possible new approach to prevention. Diabet Med. 1988 Mar;5(2):166–171. [PubMed]
  • Reckless JP, Betteridge DJ, Wu P, Payne B, Galton DJ. High-density and low-density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J. 1978 Apr 8;1(6117):883–886. [PMC free article] [PubMed]
  • Laakso M, Rönnemaa T, Pyörälä K, Kallio V, Puukka P, Penttilä I. Atherosclerotic vascular disease and its risk factors in non-insulin-dependent diabetic and nondiabetic subjects in Finland. Diabetes Care. 1988 Jun;11(6):449–463. [PubMed]
  • Walden CE, Knopp RH, Wahl PW, Beach KW, Strandness E., Jr Sex differences in the effect of diabetes mellitus on lipoprotein triglyceride and cholesterol concentrations. N Engl J Med. 1984 Oct 11;311(15):953–959. [PubMed]
  • Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: the Framingham study. Circulation. 1979 Jan;59(1):8–13. [PubMed]
  • Janka HU. Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res Suppl. 1985;15:15–19. [PubMed]
  • Rosengren A, Welin L, Tsipogianni A, Wilhelmsen L. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ. 1989 Nov 4;299(6708):1127–1131. [PMC free article] [PubMed]
  • Kennedy L, Walshe K, Hadden DR, Weaver JA, Buchanan KD. The effect of intensive dietary therapy on serum high density lipoprotein cholesterol in patients with Type 2 (non-insulin-dependent) diabetes mellitus: a prospective study. Diabetologia. 1982 Jul;23(1):24–27. [PubMed]
  • Lalor BC, Bhatnagar D, Winocour PH, Ishola M, Arrol S, Brading M, Durrington PN. Placebo-controlled trial of the effects of guar gum and metformin on fasting blood glucose and serum lipids in obese, type 2 diabetic patients. Diabet Med. 1990 Mar-Apr;7(3):242–245. [PubMed]
  • Coulston AM, Hollenbeck CB, Swislocki AL, Chen YD, Reaven GM. Deleterious metabolic effects of high-carbohydrate, sucrose-containing diets in patients with non-insulin-dependent diabetes mellitus. Am J Med. 1987 Feb;82(2):213–220. [PubMed]
  • Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 36-1988. Flank pain, hematuria, hydronephrosis, and hydroureter in a diabetic woman. N Engl J Med. 1988 Sep 8;319(10):629–640. [PubMed]
  • Lisch HJ, Sailer S. Lipoprotein patterns in diet, sulphonylurea, and insulin treated diabetics. Diabetologia. 1981 Feb;20(2):118–122. [PubMed]
  • Paisey R, Elkeles RS, Hambley J, Magill P. The effects of chlorpropamide and insulin on serum lipids, lipoproteins and fractional triglyceride removal. Diabetologia. 1978 Aug;15(2):81–85. [PubMed]
  • Greenfield MS, Doberne L, Rosenthal M, Vreman HJ, Reaven GM. Lipid metabolism in non-insulin-dependent diabetes mellitus: effect of glipizide therapy. Arch Intern Med. 1982 Aug;142(8):1498–1500. [PubMed]
  • Rains SG, Wilson GA, Richmond W, Elkeles RS. The effect of glibenclamide and metformin on serum lipoproteins in type 2 diabetes. Diabet Med. 1988 Oct;5(7):653–658. [PubMed]
  • Dall'Aglio E, Strata A, Reaven G. Abnormal lipid metabolism in treated hypertensive patients with non-insulin-dependent diabetes mellitus. Am J Med. 1988 May;84(5):899–903. [PubMed]
  • Feher MD, Rains SG, Richmond W, Torrens D, Wilson G, Wadsworth J, Sever PS, Elkeles RS. Beta-blockers, lipoproteins and non-insulin dependent diabetes. Postgrad Med J. 1988 Dec;64(758):926–930. [PMC free article] [PubMed]
  • Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects. J Hum Hypertens. 1990 Oct;4(5):571–577. [PubMed]
  • Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987 Nov 12;317(20):1237–1245. [PubMed]
  • Garg A, Grundy SM. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus. N Engl J Med. 1988 Jan 14;318(2):81–86. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press